Evidence map›Paper›PMID 40461845›Full record

ArticleNature metabolism2025

Cysteine depletion triggers adipose tissue thermogenesis and weight loss.

Aileen H Lee, Lucie Orliaguet, Yun-Hee Youm, Rae Maeda, Tamara Dlugos, Yuanjiu Lei, Daniel Coman, Irina Shchukina, Prabhakar Sairam Andhey, Steven R Smith and 9 more

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Methionine restriction and mimetics to ameliorate human aging and disease.Trends in endocrinology and metabolism: TEM · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Changes in the brain [NADFrontiers in aging neuroscience · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Aileen H Lee *Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Lucie Orliaguet *Department of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3209-457X
Yun-Hee YoumDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-8098-8527
Rae MaedaMultiomics Platform, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tamara DlugosDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.
Yuanjiu LeiDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7486-4261
Daniel ComanDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6289-0817
Irina ShchukinaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Prabhakar Sairam AndheyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Steven R SmithTranslational Research Institute for Metabolism and Diabetes, AdventHealth, Orlando, FL, USA.
Eric RavussinPennington Biomedical Research Center, Baton Rouge, LA, USA.ORCID http://orcid.org/0000-0003-2129-547X
Krisztian StadlerPennington Biomedical Research Center, Baton Rouge, LA, USA.
Bandy ChenDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, USA.
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-1133-4212
Fahmeed HyderDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-7822-4002
Tamas L HorvathDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7522-4602
Marc SchneebergerDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, USA.
Yuki SugiuraMultiomics Platform, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6983-8958
Vishwa Deep DixitDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA. Vishwa.Dixit@yale.edu.ORCID http://orcid.org/0000-0002-5341-6494

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2022 to 2026
$7.4M
Yale Murine-TMC on Immune Cell Senescence Derived InflammationU54AG079759 · NIA · YALE UNIVERSITY · PI KLUGER, YUVAL · 2022 to 2025
$6.5M
Caloric restriction-driven immunometabolic checkpoints of inflammationR01AG073969 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2022 to 2026
$2.5M
Immunometabolic regulation of bone inflammagingR01AG076782 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2022 to 2026
$2.3M
Impact of dysbiosis on the development of age-related inflammationR01AG068863 · NIA · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP, PALM, NOAH WOLCOTT · 2020 to 2024
$2.2M
Impact of Calorie Restriction on Thymopoiesis in HumansR01AG031797 · NIA · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2008 to 2015
$1.2M
Novel redox mechanisms of oxygenated phospholipids in chronic and diabetic kidney diseaseR01DK137472 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI STADLER, KRISZTIAN · 2023 to 2025
$888k
NIA NIH HHS P01 AG051459NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG031797NIA NIH HHS R01 AG068863NIA NIH HHS R01 AG073969NIA NIH HHS R01 AG076782NIA NIH HHS U54 AG079759NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK127984NIDDK NIH HHS R01 DK137472U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R00DK1208689U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG031797U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG068863U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG073969U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P01AG051459
6 · The paper itself

Abstract

Caloric restriction and methionine restriction-driven enhanced lifespan and healthspan induces 'browning' of white adipose tissue, a metabolic response that increases heat production to defend core body temperature. However, how specific dietary amino acids control adipose thermogenesis is unknown. Here, we identified that weight loss induced by caloric restriction in humans reduces thiol-containing sulfur amino acid cysteine in white adipose tissue. Systemic cysteine depletion in mice causes lethal weight loss with increased fat utilization and browning of adipocytes that is rescued upon restoration of cysteine in diet. Mechanistically, cysteine-restriction-induced adipose browning and weight loss requires sympathetic nervous system-derived noradrenaline signalling via β3-adrenergic-receptors that is independent of FGF21 and UCP1. In obese mice, cysteine deprivation induced rapid adipose browning, increased energy expenditure leading to 30% weight loss and reversed metabolic inflammation. These findings establish that cysteine is essential for organismal metabolism as removal of cysteine in the host triggers adipose browning and rapid weight loss.

Indexed as

Adipose TissueCysteineThermogenesisWeight LossAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsCaloric RestrictionEnergy MetabolismFibroblast Growth FactorsHumansMaleMiceMice, Inbred C57BLObesityReceptors, Adrenergic, beta-3Cysteinefibroblast growth factor 21Fibroblast Growth FactorsReceptors, Adrenergic, beta-3Uncoupling Protein 1

Identifiers

PMID40461845
PMCPMC12198010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.